NASDAQ NMS - GLOBAL MARKET · GENB
+1.61% · +$0.2600 · Vol Not reported
Pre-market · updated 04:00:00 ET
Generate Biomedicines Inc

Generate Biomedicines Inc

Biotechnology
$16.38
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
GENB
Generate Biomedicines Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

54/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is GENB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading GENB catalysts
About Generate Biomedicines Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2026
Country
US

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$16.12
Last session
Day high
$16.12
Last session
Day low
$16.12
Last session
Previous close
$16.12
52W high
$17.41
-5.92% from high
52W low
$11.21
83% of range
Market cap
$2.1B
EPS
$-3.1800
Beta
1.36
Shares out
128.4M
Avg volume
559.4K
VWAP
$16.12
Last session
Price history computed in-house
1W
+4.40%
1M
+22.24%
3M
+22.79%
SMA 50 $14.83 · above
SMA 200 Not reported · Not reported
52W position 83%

GENB overview

Veridion Score
54
Registered · 2026-08-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around GENB.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading GENB Form 4 filings
Public disclosures

Congress activity in GENB

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for GENB in the cached public ledger.

Federal contracts

GENB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GENB in this window.
Lobbying spend

GENB lobbying filings, year to date.

Registered lobbying filings matched to Generate Biomedicines Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GENB in this window.
Loading news for GENB
Analyst ratings
Sovereign unlock shows live analyst consensus for GENB.
Options
Sovereign unlock shows live options positioning for GENB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.